Polysaccharides

DBCAT000669Pharmacologic class

A broad class of substances encompassing all those that do not include carbon and its derivatives as their principal elements. However, carbides, carbonates, cyanides, cyanates, and carbon disulfide are included in this class. A DrugBank category of 130 drugs. 61 of them are approved.

Also known as: Glycans
Drugs: 2-Hydroxylpropyl-beta-cyclodextrin
2'-Fucosyllactose
4-methyl-umbelliferyl-N-acetyl-chitobiose
Acacia
Acarbose
Acemannan
Alginic acid
Allolactose
Allosamidin
Amylopectin
Amylose
Antihemophilic factor, human recombinant
Antithrombin III human
Ardeparin
Ataprost
Avilamycin
Bambermycins
Belapectin
Bemiparin
Beta-(1,3)-D glucan
beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranose
Betadex
Brexanolone
Calcium alginate
Calcium glubionate anhydrous
and 105 more with a free account

What you can answer from here — as of August 24, 2016

130DrugsEach linked to its full drug card

170Drug targetsEvery drug–target pair in the class, with bond type

5,339Marketed productsAcross the regions we cover, with dosage forms and routes

31Routes of administrationHow the drugs in this class are given

Which targets do Polysaccharides share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account